228 related articles for article (PubMed ID: 35057106)
1. Molecular Engineering of Peptide-Drug Conjugates for Therapeutics.
Fang Y; Wang H
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057106
[TBL] [Abstract][Full Text] [Related]
2. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
[TBL] [Abstract][Full Text] [Related]
3. Peptide-drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?
Fu C; Yu L; Miao Y; Liu X; Yu Z; Wei M
Acta Pharm Sin B; 2023 Feb; 13(2):498-516. PubMed ID: 36873165
[TBL] [Abstract][Full Text] [Related]
4. Intracellular Self-Assembly of Peptide Conjugates for Tumor Imaging and Therapy.
Deng Y; Zhan W; Liang G
Adv Healthc Mater; 2021 Jan; 10(1):e2001211. PubMed ID: 32902191
[TBL] [Abstract][Full Text] [Related]
5. Peptide-drug conjugates: A new paradigm for targeted cancer therapy.
Wang M; Liu J; Xia M; Yin L; Zhang L; Liu X; Cheng Y
Eur J Med Chem; 2024 Feb; 265():116119. PubMed ID: 38194773
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal Self-Assembly of Peptide-DNA Conjugates into a Programmable Sub-10-nm Supramolecular Deoxyribonucleoprotein.
Kye M; Lim YB
Angew Chem Int Ed Engl; 2016 Sep; 55(39):12003-7. PubMed ID: 27553897
[TBL] [Abstract][Full Text] [Related]
7. Self-assembling peptide-based building blocks in medical applications.
Acar H; Srivastava S; Chung EJ; Schnorenberg MR; Barrett JC; LaBelle JL; Tirrell M
Adv Drug Deliv Rev; 2017 Feb; 110-111():65-79. PubMed ID: 27535485
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in self-assembled peptides: Implications for targeted drug delivery and vaccine engineering.
Eskandari S; Guerin T; Toth I; Stephenson RJ
Adv Drug Deliv Rev; 2017 Feb; 110-111():169-187. PubMed ID: 27356149
[TBL] [Abstract][Full Text] [Related]
9. Research advances in peptide‒drug conjugates.
Gong L; Zhao H; Liu Y; Wu H; Liu C; Chang S; Chen L; Jin M; Wang Q; Gao Z; Huang W
Acta Pharm Sin B; 2023 Sep; 13(9):3659-3677. PubMed ID: 37719380
[TBL] [Abstract][Full Text] [Related]
10. Peptide-Drug Conjugate: A Novel Drug Design Approach.
Ma L; Wang C; He Z; Cheng B; Zheng L; Huang K
Curr Med Chem; 2017; 24(31):3373-3396. PubMed ID: 28393694
[TBL] [Abstract][Full Text] [Related]
11. Drug delivery with nanospherical supramolecular cell penetrating peptide-taxol conjugates containing a high drug loading.
Tian R; Wang H; Niu R; Ding D
J Colloid Interface Sci; 2015 Sep; 453():15-20. PubMed ID: 25956129
[TBL] [Abstract][Full Text] [Related]
12. Construction of Peptide-Drug Conjugates for Selective Targeting of Malignant Tumor Cells.
Vrettos EI; Tzakos AG
Methods Mol Biol; 2021; 2207():327-338. PubMed ID: 33113145
[TBL] [Abstract][Full Text] [Related]
13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
14. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
15. A Peptide Nanocage Constructed by Self-Assembly of Oligoproline Conjugates.
Matsubara S; Okamoto Y; Yoshikawa M; Tsukiji S; Higuchi M
Bioconjug Chem; 2022 Oct; 33(10):1785-1788. PubMed ID: 35900377
[TBL] [Abstract][Full Text] [Related]
16. Self-assembly behaviours of peptide-drug conjugates: influence of multiple factors on aggregate morphology and potential self-assembly mechanism.
Fan Q; Ji Y; Wang J; Wu L; Li W; Chen R; Chen Z
R Soc Open Sci; 2018 Apr; 5(4):172040. PubMed ID: 29765659
[TBL] [Abstract][Full Text] [Related]
17. Antiviral Peptide-Based Conjugates: State of the Art and Future Perspectives.
Todorovski T; Kalafatovic D; Andreu D
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839679
[TBL] [Abstract][Full Text] [Related]
18. On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site.
Vrettos EI; Mező G; Tzakos AG
Beilstein J Org Chem; 2018; 14():930-954. PubMed ID: 29765474
[TBL] [Abstract][Full Text] [Related]
19. Peptides as a platform for targeted therapeutics for cancer: peptide-drug conjugates (PDCs).
Cooper BM; Iegre J; O' Donovan DH; Ölwegård Halvarsson M; Spring DR
Chem Soc Rev; 2021 Feb; 50(3):1480-1494. PubMed ID: 33346298
[TBL] [Abstract][Full Text] [Related]
20. Self-assembled short peptides: Recent advances and strategies for potential pharmaceutical applications.
Yang S; Wang M; Wang T; Sun M; Huang H; Shi X; Duan S; Wu Y; Zhu J; Liu F
Mater Today Bio; 2023 Jun; 20():100644. PubMed ID: 37214549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
